Yahoo
    NZSE - Delayed Quote NZD

    AFT Pharmaceuticals Limited (AFT.NZ)

    4.5900 +0.0900 (+2.00%)
    As of 4:20:06 PM GMT+13. Market Open.
    Loading Chart for AFT.NZ
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    AFT Pharmaceuticals partners with Mark Cuban Cost Plus Marketplace to bring the new non-opioid pain medication, Combogesic® to the U.S.

    AFT Pharmaceuticals partners with Mark Cuban Cost Plus Marketplace to bring the new non-opioid pain medication, Combogesic® to the U.S.
    PR Newswire 1mo ago
    AFT Pharmaceuticals Ltd (ASX:AFP) Full Year 2026 Earnings Call Highlights: Strong Revenue ...

    AFT Pharmaceuticals Ltd (ASX:AFP) Full Year 2026 Earnings Call Highlights: Strong Revenue ...
    GuruFocus.com 5mo ago
    Earnings Miss: AFT Pharmaceuticals Limited Missed EPS By 6.7% And Analysts Are Revising Their Forecasts

    Earnings Miss: AFT Pharmaceuticals Limited Missed EPS By 6.7% And Analysts Are Revising Their Forecasts
    Simply Wall St. 5mo ago
    Here's Why AFT Pharmaceuticals (NZSE:AFT) Has Caught The Eye Of Investors

    Here's Why AFT Pharmaceuticals (NZSE:AFT) Has Caught The Eye Of Investors
    Simply Wall St. 6mo ago
    AFT Pharmaceuticals Limited's (NZSE:AFT) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

    AFT Pharmaceuticals Limited's (NZSE:AFT) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
    Simply Wall St. 8mo ago
    Owning 69% in AFT Pharmaceuticals Limited (NZSE:AFT) means that insiders are heavily invested in the company's future

    Owning 69% in AFT Pharmaceuticals Limited (NZSE:AFT) means that insiders are heavily invested in the company's future
    Simply Wall St. 9mo ago
    AFT Pharmaceuticals (NZSE:AFT) shareholders have endured a 33% loss from investing in the stock five years ago

    AFT Pharmaceuticals (NZSE:AFT) shareholders have endured a 33% loss from investing in the stock five years ago
    Simply Wall St. 9mo ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: